Sign Up to like & get recommendations! 0
Published in 2020 at "JAMA dermatology"
DOI: 10.1001/jamadermatol.2020.2927
Abstract: Clinical Question Who should receive human papillomavirus (HPV) vaccination? Bottom Line Catch-up vaccination is now recommended for all persons through age 26 years. For persons aged 27 through 45 years, clinicians and patients should now… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "JAMA dermatology"
DOI: 10.1001/jamadermatol.2022.3500
Abstract: This cross-sectional study examines state Medicaid coverage of human papillomavirus vaccination in adults aged 27 to 45 years and discusses the implications of the results for dermatologists. read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2019.14031
Abstract: This cohort study assesses associations between sexual activity, the oral presence of human papillomavirus (HPV), and HPV vaccination among sexually active female adolescents vaccinated against 4 HPV types. read more here.
Sign Up to like & get recommendations! 1
Published in 2021 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2021.15321
Abstract: Key Points Question As human papillomavirus (HPV)–based cervical screening modalities change and HPV vaccination becomes more widespread, what are the likely outcomes for the interpretation of screening modalities? Findings In this decision analytical model with… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2021.20391
Abstract: This cohort study investigates the risk of primary ovarian insufficiency after human papillomavirus vaccination among Danish girls and women. read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.2530
Abstract: Key Points Question Are human papillomavirus (HPV) vaccinations and screening associated with trends in HPV-associated cancers in the US? Findings In this cross-sectional study using 3 national databases, the incidence of cervical cancer has decreased,… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.38041
Abstract: This survey study assesses the status and timing of HPV vaccination as self-reported by female participants in the National Health and Nutrition Examination Survey from 2011 to 2018. read more here.
Sign Up to like & get recommendations! 2
Published in 2023 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.55971
Abstract: This case series assesses the incidence of human papillomavirus (HPV)-associated sinonasal squamous cell carcinoma (SNSCC) and the prevalence of HPV-positive SNSCC among US adults. read more here.
Sign Up to like & get recommendations! 2
Published in 2023 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2023.3949
Abstract: Key Points Question What are the experiences and attitudes of Swiss university students regarding receiving human papillomavirus vaccination during primary care visits? Findings In this survey study of 5524 Swiss university students, of whom 740… read more here.
Sign Up to like & get recommendations! 2
Published in 2023 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2023.4052
Abstract: Key Points Question What is the cost-effectiveness of mailing human papillomavirus self-sampling kits relative to usual care for increasing cervical cancer screening rates among underscreened female members of an integrated US health care system? Findings… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "JAMA Oncology"
DOI: 10.1001/jamaoncol.2017.1040
Abstract: Importance Little is known about the long-term yield of high-grade cervical intraepithelial neoplasia (CIN) and the influence on biopsy and treatment rates of human papillomavirus (HPV) triage of cytology showing atypical squamous cells of undetermined… read more here.